Exelixis Clinical Site #15

New York, New York 10065

0 studies enrolling now · 1 studies all time

What they study most

Non-Clear Cell Renal Cell Carcinoma

Studies at this site

• Study of XL092 + Nivolumab vs Sunitinib in Subjects With Advanced or Metastatic Non-Clear Cell Renal Cell Carcinoma — Running, not enrolling